New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2013
12:09 EDTASTMAastrom downgraded to Sell from Neutral at Roth Capital
Roth Capital downgraded Aastrom to Sell with a 25c price target after the company said it will stop enrollment and end the Phase 3 REVIVE clinical trial in patients with critical limb ischemia.
News For ASTM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ASTM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use